Dr Rolando J Lindo Jr, MD | |
6600 North Desert Boulevard, El Paso, TX 79912 | |
(915) 790-5700 | |
Not Available |
Full Name | Dr Rolando J Lindo Jr |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 12 Years |
Location | 6600 North Desert Boulevard, El Paso, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306265046 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | R2393 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Medical Center Of El Paso | El paso, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
El Paso County Hospital District | 2365431509 | 118 |
News Archive
Use of marijuana in combination with alcohol by drivers is especially dangerous, according to a latest study conducted at Columbia University's Mailman School of Public Health.
A study conducted in Sydney during the early epidemic stage of COVID-19 has found an association between lower humidity and an increase in locally acquired positive cases. Researchers discovered a 1 percent decrease in humidity could increase the number of COVID-19 cases by 6 percent.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
Takeda Pharmaceutical Company Limited today announced top-line results from the international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase 3 trial. The trial evaluated vedolizumab in 1,115 patients with moderately to severely active Crohn's disease who have failed at least one conventional therapy, including TNFα antagonists.
Conditions such as Parkinson's disease are a result of pathogenic changes to proteins. In the neurodegenerative condition of Parkinson's disease, which is currently incurable, the alpha-synuclein protein changes and becomes pathological. Until now, there have not been any antibodies that could help to demonstrate the change in alpha-synuclein associated with the disease. An international team of experts led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now discovered a new antibody that actually possesses this ability.
› Verified 4 days ago
Entity Name | El Paso County Hospital District |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316936990 PECOS PAC ID: 2365431509 Enrollment ID: O20040511001452 |
News Archive
Use of marijuana in combination with alcohol by drivers is especially dangerous, according to a latest study conducted at Columbia University's Mailman School of Public Health.
A study conducted in Sydney during the early epidemic stage of COVID-19 has found an association between lower humidity and an increase in locally acquired positive cases. Researchers discovered a 1 percent decrease in humidity could increase the number of COVID-19 cases by 6 percent.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
Takeda Pharmaceutical Company Limited today announced top-line results from the international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase 3 trial. The trial evaluated vedolizumab in 1,115 patients with moderately to severely active Crohn's disease who have failed at least one conventional therapy, including TNFα antagonists.
Conditions such as Parkinson's disease are a result of pathogenic changes to proteins. In the neurodegenerative condition of Parkinson's disease, which is currently incurable, the alpha-synuclein protein changes and becomes pathological. Until now, there have not been any antibodies that could help to demonstrate the change in alpha-synuclein associated with the disease. An international team of experts led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now discovered a new antibody that actually possesses this ability.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Rolando J Lindo Jr, MD 5829 6th St Apt C, Lubbock, TX 79416-4525 Ph: (575) 268-1286 | Dr Rolando J Lindo Jr, MD 6600 North Desert Boulevard, El Paso, TX 79912 Ph: (915) 790-5700 |
News Archive
Use of marijuana in combination with alcohol by drivers is especially dangerous, according to a latest study conducted at Columbia University's Mailman School of Public Health.
A study conducted in Sydney during the early epidemic stage of COVID-19 has found an association between lower humidity and an increase in locally acquired positive cases. Researchers discovered a 1 percent decrease in humidity could increase the number of COVID-19 cases by 6 percent.
Obesity, diabetes, and cardiovascular diseases are daunting modern-day epidemics. In Western Europe more than 50% of the population is overweight and approximately 15 million people die from cardiovascular diseases such as heart attacks and stroke every year. These conditions are often caused by disorders of fat metabolism, resulting in a massive accumulation of fat in various tissues and of cholesterol in the walls of arteries.
Takeda Pharmaceutical Company Limited today announced top-line results from the international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase 3 trial. The trial evaluated vedolizumab in 1,115 patients with moderately to severely active Crohn's disease who have failed at least one conventional therapy, including TNFα antagonists.
Conditions such as Parkinson's disease are a result of pathogenic changes to proteins. In the neurodegenerative condition of Parkinson's disease, which is currently incurable, the alpha-synuclein protein changes and becomes pathological. Until now, there have not been any antibodies that could help to demonstrate the change in alpha-synuclein associated with the disease. An international team of experts led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has now discovered a new antibody that actually possesses this ability.
› Verified 4 days ago
Mr. Jaime I Jaraba Jr., MD Family Medicine Medicare: Medicare Enrolled Practice Location: 9999 Kenworthy St Ste 1000, El Paso, TX 79924 Phone: 915-298-3434 Fax: 915-751-7257 | |
Kristina Sinnott, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Transmountain Rd Ste B, El Paso, TX 79911 Phone: 915-215-8400 Fax: 915-612-9253 | |
Dr. Jonnalyn R. Belocura, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 11345 Montwood Dr, Suite A-1, El Paso, TX 79936 Phone: 915-921-5200 Fax: 915-921-5299 | |
Dr. Leo Lawrence Altenberg, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 154 N Festival Dr, Ste A, El Paso, TX 79912 Phone: 806-647-2194 Fax: 806-647-3769 | |
Pamela J Richter, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 730 East Yandell Dr, El Paso, TX 79902 Phone: 210-824-9939 Fax: 915-544-5957 | |
Paola Alejandra Cossiorojas, PA Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 5005 N Piedras St, El Paso, TX 79920 Phone: 915-742-2273 | |
Dr. Hye Tae Kim, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1387 George Dieter Dr Bldg B, El Paso, TX 79936 Phone: 915-275-0224 Fax: 915-275-0225 |